Erratum: HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites (J. Med. Chem. (2021) 64: 22 (16530−16540) DOI: 10.1021/acs.jmedchem.1c01104)

Natalie Losada, Francesc X. Ruiz, Francesca Curreli, Kevin Gruber, Alyssa Pilch, Andrea Altieri, Alexander V. Kurkin, Kalyan Das, Asim K. Debnath, Eddy Arnold

Research output: Contribution to journalComment/debatepeer-review

Abstract

The author list has been corrected to include authors Andrea Altieri and Alexander V. Kurkin. The author affiliation address for Andrea Altieri and Alexander V. Kurkin is: EDASA Scientific, Scientific Park, Moscow State University, Leninskie Gory, Bld. 75, 77-101b, 119992 Moscow, Russia Dr. Altieri and Dr. Kurkin made very significant contributions by synthesizing the reported compounds and carrying out their full characterization, including the LC-MS data presented.

Original languageEnglish (US)
Pages (from-to)885
Number of pages1
JournalJournal of medicinal chemistry
Volume65
Issue number1
DOIs
StatePublished - Jan 13 2022

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites (J. Med. Chem. (2021) 64: 22 (16530−16540) DOI: 10.1021/acs.jmedchem.1c01104)'. Together they form a unique fingerprint.

Cite this